Oncogene-Directed Therapies

图书简介

Prominent investigators and clinicians summarize in a balanced blend of fundamental science, basic research, experimental therapeutics, and early clinical experiences, what is known about oncogenes and oncogenesis, and describe how that knowledge can be used to treat the cancer. The contributors explain how, why, and under what conditions certain proteins acquire the ability to transform eukaryotic cells, and detail the crucial biological consequences of this oncogenic transformation, particularly for cellular mitogenesis, survival, differentiation, migration, proteolysis, or angiogenic competence. Their articles thoroughly explicate the premises, principles, techniques, and approaches to oncogene targeting in various types of human cancer by using signal transduction inhibitors, immunological targeting methods, and antisense gene therapy.

I. Basic Concepts in Oncogene Research.- 1 Genetic Basis of Cancer Progression.- 2 The Molecular Basis of Chromosomal Instability in Human Cancer Cells.- 3 Signal Transduction Networks: Ras as a Paradigm.- 4 Oncogenic Receptor Tyrosine Kinases.- 5 Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis.- 6 The Interplay Between Tumor Suppressor Genes and Oncogenes in Tumorigenesis.- 7 Genetic Basis of Altered Responsiveness of Cancer Cells to Their Microenvironment.- II. The Functional Impact of Oncogene Expression on Cancer Cellstherapeutic Implications.- 8 Deregulation of Cell Cycle Progression by Oncogenic Transformation.- 9 Oncogenes as Regulators of Cell Survival: The Role of Oncogenes and Tumor Suppressor Genes in the Induction of Resistance to Anoikis and Hypoxia.- 10 Oncogenes and Tumor Angiogenesis.- 11 Oncogenes as Therapeutic Targets to Prevent Metastasis.- 12 The Impact of Oncogenes on Tumor Maintenance.- 13 Primary and Secondary Events in Oncogene-Driven Tumor Development: Lessons from Transgenic Model Systems.- III. Oncogenes as Targets for Anticancer Therapy In Vivo.- 14 Targeting Oncogenes in Hematopoietic Malignancies.- 15 Clinical Evaluation of Agents Targeting Epidermal Growth Factor Receptor (EGFR) in Cancer.- 16 Inhibition of the HER-2/neu Oncogene: A Translational Research Model for the Development of Future Targeted Therapies.- 17 Farnesyltransferase Inhibitors as Anticancer Agents.- 18 Targeting Oncogenic Signaling Pathways in Human Astrocytomas.- 19 Targeting Oncogenes in Pediatric Malignancies.- 20 Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells.- 21 Oncogenes as Targets for Cancer Vaccines.- 22 Bcl-2 Antisense Oligonucleotides Therapy for Cancer: Targeting the Mitochondria.

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Oncogene-Directed Therapies（Cancer Drug Discovery and Development） 肿瘤学

Oncogene-Directed Therapies（Cancer Drug Discovery and Development）
肿瘤学